Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: A controlled study

Journal of the American College of Cardiology

Volumn 35, Issue 6, 2000, Pages 1554-1559

  Schofer, Joachim ^a   Schlüter, Michael ^a   Rau, Thomas ^a   Hammer, Falk ^a   Haag, Natalie ^a   Mathey, Detlef G ^a  

^a Center for Cardiology Othmarschen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DIABETES MELLITUS; DIET THERAPY; FEMALE; FOLLOW UP; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE;

EID: 0342424770     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00574-X     Document Type: Article

References (25)

1. Stein B., Weintraub W.S., Gebhart S.P., et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 91:1995;979-989.
2. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation. Circulation. 96:1997;1761-1769.
3. Kip K.E., Faxon D.P., Detre K.M., Yeh W., Kelsey S.F., Currier J.W. Coronary angioplasty in diabetic patients the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry . Circulation. 94:1996;1818-1825.
4. Weintraub W.S., Stein B., Kosinski A., et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 31:1998;10-19.
5. O'Neill W.W. Multivessel balloon angioplasty should be abandoned in diabetic patients! J Am Coll Cardiol. 31:1998;20-22.
6. Ferguson J.J. NHLI BARI clinical alert on diabetics treated with angioplasty. Circulation. 92:1995;3371.
7. Van Belle E., Bauters C., Hubert E., et al. Restenosis rates in diabetic patients a comparison of coronary stenting and balloon angioplasty in native coronary vessels . Circulation. 96:1997;1454-1460.
8. Kastrati A., Schömig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 30:1997;1428-1436.
9. Abizaid A., Kornowski R., Mintz G.S., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 32:1998;584-589.
10. Lau K.W., Ding Z.P., Johan A., Lim Y.L. Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients a matched comparative study . Am Heart J. 136:1998;150-155.
11. Kornowski R., Mintz G.S., Kent K.M., et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia a serial intravascular ultrasound study . Circulation. 95:1997;1366-1369.
12. Dussaillant G.R., Mintz G.S., Pichard A.D., et al. Small stent size and intimal hyperplasia contribute to restenosis a volumetric intravascular ultrasound analysis . J Am Coll Cardiol. 26:1995;720-724.
13. Aronson D., Bloomgarden Z., Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 27:1996;528-535.
14. Ledet T. Growth of rabbit aortic smooth muscle cells in serum from patients with juvenile diabetes. Acta Pathol Microbiol Scand [A]. 84:1976;508-516.
15. McClain D.A., Paterson A.J., Roos M.D., Wei X., Kudlow J.E. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA. 89:1992;8150-8154.
16. Inaba T., Ishibashi S., Gotoda T., et al. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose involvement of platelet-derived growth factor in diabetic angiopathy . Diabetes. 45:1996;507-512.
17. Kawano M., Koshikawa T., Kanzaki T., Morisaki N., Saito Y., Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells association with overexpression of PDGF-beta receptors . Eur J Clin Invest. 23:1993;84-90.
18. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
19. Oliver F.J., de la Rubia G., Feener E.P., et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 266:1991;23251-23256.
20. Banskota N.K., Taub R., Zellner K., King G.L. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol. 3:1989;1183-1190.
21. Tschöpe D., Rösen P., Esser J., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 17:1991;433-438.
22. Ceriello A. Coagulation activation in diabetes mellitus the role of hyperglycaemia and therapeutic prospects . Diabetologia. 36:1993;1119-1125.
23. De Feo P., Gaisano M.G., Haymond M.W. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest. 88:1991;833-840.
24. McGill J.B., Schneider D.J., Arfken C.L., Lucore C.L., Sobel B.E. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes. 43:1994;104-109.
25. Kuntz R.E., Gibson M., Nobuyoshi M., Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 21:1993;15-25.